Related Experiment Video
Updated: Apr 20, 2026
10:33
Detecting Migration and Infiltration of Neutrophils in Mice
Published on: February 6, 2020
13.0K
Curcumin loaded solid lipid nanoparticles ameliorate adjuvant-induced arthritis in rats
1Pharmacology Research Laboratory, University Institute of Pharmaceutical Sciences, UGC Center of Advanced Study, Panjab University, Chandigarh, India.
European Journal of Pain (London, England)
|November 18, 2014
Summary
Curcumin loaded solid lipid nanoparticles (C-SLNs) effectively treat rheumatoid arthritis in rats by reducing inflammation and joint damage. This novel delivery system enhances curcumin
Area of Science:
- Pharmacology and Nanotechnology
- Rheumatology and Immunology
Background:
- Rheumatoid arthritis (RA) is a chronic inflammatory disease causing joint destruction.
- Curcumin shows anti-inflammatory effects but suffers from poor bioavailability.
- Solid lipid nanoparticles (SLNs) offer a solution for enhanced curcumin delivery.
Purpose of the Study:
- To evaluate the therapeutic potential of curcumin-loaded solid lipid nanoparticles (C-SLNs) for rheumatoid arthritis.
- To investigate the efficacy of C-SLNs in an animal model of arthritis.
Main Methods:
- Complete Freund's adjuvant (CFA)-induced arthritis model in rats.
- Administration of free curcumin versus C-SLNs at different doses.
- Assessment of pain, joint function, biochemical markers, and radiological changes.
Main Results:
- C-SLNs significantly ameliorated arthritis symptoms, including pain and joint swelling.
- C-SLNs improved biochemical markers of inflammation and oxidative stress.
- C-SLNs preserved joint integrity and reduced radiological damage compared to free curcumin.
Conclusions:
- Curcumin-SLNs demonstrate significant protective effects against collagen-induced arthritis in rats.
- SLNs enhance curcumin's bioavailability and therapeutic efficacy for RA.
- This approach offers a promising strategy for treating rheumatoid arthritis.
